Further experiments are needed to find out whether the IGFBP-4 gene therapy can be combined with chemotherapeutic agents in preventing the establishment of colon cancer in situations such as familial adenomatous polyposis. This evidence concerns the gene IGFBP4 and malignant colon neoplasm.